Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![WealthWithRG Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::232380002.png) Robert Gilliland [@WealthWithRG](/creator/twitter/WealthWithRG) on x 5218 followers
Created: 2025-07-23 20:32:53 UTC

$AVXL peer reviewed JPAD article endorsed by XX Alzheimer authorities reports excellent data with even stronger long-term OLE results.

Non-cancer candidates at this stage carry over XX % EMA approval odds.

Experts value a European approval at $XX B and a U S approval at $XX B, while the current market cap sits near $X B.

Do the math.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948119146002329767/c:line.svg)

**Related Topics**
[market cap](/topic/market-cap)
[ole](/topic/ole)
[longterm](/topic/longterm)
[$avxl](/topic/$avxl)

[Post Link](https://x.com/WealthWithRG/status/1948119146002329767)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

WealthWithRG Avatar Robert Gilliland @WealthWithRG on x 5218 followers Created: 2025-07-23 20:32:53 UTC

$AVXL peer reviewed JPAD article endorsed by XX Alzheimer authorities reports excellent data with even stronger long-term OLE results.

Non-cancer candidates at this stage carry over XX % EMA approval odds.

Experts value a European approval at $XX B and a U S approval at $XX B, while the current market cap sits near $X B.

Do the math.

XXX engagements

Engagements Line Chart

Related Topics market cap ole longterm $avxl

Post Link

post/tweet::1948119146002329767
/post/tweet::1948119146002329767